Market Cap

Travere Therapeutics Inc. Market Capitalization:

$600.7 Million

USD as of July 1, 2024

business Travere Therapeutics Inc. Company Profile

Travere Therapeutics Inc. Main Stock Listing

NASDAQ: TVTX

Market Capitalization History of Travere Therapeutics Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Travere Therapeutics Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2024 $649.3 M -50.36%
Jan. 1, 2023 $1.31 B -24.73%
Jan. 1, 2022 $1.74 B 8.91%
Jan. 1, 2021 $1.60 B 63.32%
Jan. 1, 2020 $976.8 M -28.29%
Jan. 1, 2019 $1.36 B -9.83%
Jan. 1, 2018 $1.51 B 21.87%
Jan. 1, 2017 $1.24 B 31.06%
Jan. 1, 2016 $945.8 M 16.59%
Jan. 1, 2015 $811.3 M 21.36%
Jan. 1, 2014 $668.5 M 135.11%
Jan. 1, 2013 $284.3 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Travere Therapeutics Inc. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Travere Therapeutics Inc. has the following listings and related stock indices.


Stock: NASDAQ: TVTX

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.